home / stock / azn / azn news


AZN News and Press, AstraZeneca PLC From 04/25/24

Stock Information

Company Name: AstraZeneca PLC
Stock Symbol: AZN
Market: NYSE
Website: astrazeneca.com

Menu

AZN AZN Quote AZN Short AZN News AZN Articles AZN Message Board
Get AZN Alerts

News, Short Squeeze, Breakout and More Instantly...

AZN - AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript

2024-04-25 12:30:13 ET Image source: The Motley Fool. AstraZeneca Plc (NASDAQ: AZN) Q1 2024 Earnings Call Apr 25, 2024 , 6:45 a.m. ET Operator Continue reading For further details see: AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript

AZN - AstraZeneca PLC (AZN) Q1 2024 Earnings Call Transcript

2024-04-25 12:20:08 ET AstraZeneca PLC (AZN) Q1 2024 Earnings Conference Call April 25, 2024 06:45 AM ET Company Participants Andy Barnett - Head of Investor Relations Pascal Soriot - Executive Director and Chief Executive Officer Aradhana Sarin - Executive Direc...

AZN - AZN, BGC, EQT, AMBP, BZ showing five-day upward surge

2024-04-25 10:45:03 ET Astrazeneca plc (AZN) AZN is trading UP for the last 5 days, and it at trading at $74.96 with volume of 5,311,776 and a one day change of $3.76 (5.27%). Astrazeneca plc has a 52-week low of 60.47 and a 52-week high of $76.56. The business's 50-day moving avera...

AZN - AstraZeneca PLC (NASDAQ: AZN) Highlighted for Surprising Price Action

AstraZeneca PLC (NASDAQ: AZN) has caught the attention of the investment community today with its bullish price action. The company's shares have moved 5.38% on the day to $75.03. AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercial...

AZN - AstraZeneca rises as oncology business drives Q1 beat

2024-04-25 08:37:36 ET More on AstraZeneca AstraZeneca: What The Market's Missing What AstraZeneca Is Getting Through The Acquisition Of Fusion Pharmaceuticals 5 Reasons AstraZeneca Stock Can Rise In 2024 AstraZeneca beats top-line and bottom-line estimates; ...

AZN - AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting

AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting PR Newswire ROCKVILLE, Md. , April 25, 2024 /PRNewswire/ -- AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global cl...

AZN - Expected US Company Earnings on Thursday, April 25th, 2024

Repsol S.A ADR (REPYY) is expected to report $0.86 for Q1 2024 Chugai Pharmaceutical Co Ltd ADR (CHGCY) is expected to report for Q1 2024 CBIZ Inc. (CBZ) is expected to report $1.57 for Q1 2024 Financial Institutions Inc. (FISI) is expected to report $0.66 for Q1 2024 Caterpillar ...

AZN - Biggest stock movers today: META, IBM, F, and more

2024-04-25 05:54:44 ET More on related stocks: International Business Machines Corporation (IBM) Q1 2024 Earnings Call Transcript Ford Motor Company (F) Q1 2024 Earnings Call Transcript ServiceNow tumbles as FX hits guidance, overshadows Q1 results (update) M...

AZN - AstraZeneca beats top-line and bottom-line estimates; reaffirms FY24 outlook

2024-04-25 02:24:51 ET More on AstraZeneca: AstraZeneca: What The Market's Missing What AstraZeneca Is Getting Through The Acquisition Of Fusion Pharmaceuticals 5 Reasons AstraZeneca Stock Can Rise In 2024 Liquid biopsy firm Angle signs new commercial agreeme...

AZN - Q1 2024 results

Very strong revenue and EPS growth in the first quarter coupled with exciting pipeline delivery AstraZeneca: Revenue and EPS summary Financial performance for Q1 2024 (Growth numbers at CER) Total Revenue up 19% to $12,679m, driven by an 18% increase in Product Sal...

Previous 10 Next 10